|
The customer observed falsely elevated creatinine results on the architect c4000 analyzer.The following data was provided: initial 6.7, repeat 0.88, 0.77, 1.0, 0.8, 1.0 mg/dl.The customer was admitted to the hospital for observation, had additional blood draws, and was caused undue stress due to the falsely elevated result.However, no negative impact to patient management was reported.
|
|
Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, review of field data, and a review of labeling.No adverse trend was identified for the customer's issue.No return patient sample was available.Historical performance of the reagent lot was evaluated using world wide data.The patient data was analyzed and within established control limits.Labeling was reviewed and found to be adequate.Based on all available information and abbott diagnostics' complaint investigation no product deficiency was identified.
|